# Uxin Ltd: Form 20-F for the period ended Dec 31, 2024

- Company: [Uxin Ltd](/companies/uxin.md) (CIK 1729173)
- Form: 20-F
- Filed: 2025-04-30
- Accepted by EDGAR: Apr 30, 2025, 06:54 ET
- Period: 2024-12-31
- Accession: 0001641172-25-006780
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1729173/000164117225006780/form20-f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1729173/000164117225006780/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 9 months, 2024-04-01 to 2024-12-31 | $204.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 9 months, 2024-04-01 to 2024-12-31 | $190.8m | us-gaap:CostOfRevenue |
| Gross profit | 9 months, 2024-04-01 to 2024-12-31 | $14.0m | us-gaap:GrossProfit |
| Research and development | 9 months, 2024-04-01 to 2024-12-31 | $1.1m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 9 months, 2024-04-01 to 2024-12-31 | −$23.9m | us-gaap:OperatingIncomeLoss |
| Interest expense | 9 months, 2024-04-01 to 2024-12-31 | $9.5m | us-gaap:InterestExpense |
| Income tax | 9 months, 2024-04-01 to 2024-12-31 | $5.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 9 months, 2024-04-01 to 2024-12-31 | −$27.3m | us-gaap:ProfitLoss |
| Diluted EPS | 9 months, 2024-04-01 to 2024-12-31 | $0.00 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 9 months, 2024-04-01 to 2024-12-31 | $0.00 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 9 months, 2024-04-01 to 2024-12-31 | 56,744,742,647 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2024-04-01 to 2024-12-31 | −$26.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2024-04-01 to 2024-12-31 | $707.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2024-12-31 | $3.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2024-12-31 | $46.5m | us-gaap:AssetsCurrent |
| Total assets | at 2024-12-31 | $267.4m | us-gaap:Assets |
| Current liabilities | at 2024-12-31 | $104.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2024-12-31 | $296.6m | us-gaap:Liabilities |
| Long-term debt | at 2024-12-31 | $7.4m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2024-12-31 | −$50.4m | us-gaap:StockholdersEquity |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1729173/000164117225006780/form20-f.htm

Filed Apr 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001641172-25-006780. Last ingested by Listed: Nov 6, 2026, 12:28 ET. No prices; not investment advice.